The contribution of physics to Nuclear Medicine: physicians’ perspective on future directions

por Mankoff, David A, Pryma, Daniel A
Publicado 2014

Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Radiation Therapy Treatment Planning: A Review of PET Imaging Tracers and Methods to Incorporate PET/CT

por Trotter, Jacob, Pantel, Austin R., Teo, Boon-Keng Kevin, Escorcia, Freddy E., Li, Taoran, Pryma, Daniel A., Taunk, Neil K.
Publicado 2023

Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma

por Jimenez, Camilo, Chin, Bennett B, Noto, Richard B, Dillon, Joseph S, Solnes, Lilja, Stambler, Nancy, DiPippo, Vincent A, Pryma, Daniel A
Publicado 2022

The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes

por Guerraty, Marie A., Rao, H. Shanker, Anjan, Venkatesh Y., Szapary, Hannah, Mankoff, David A., Pryma, Daniel A., Rader, Daniel J., Dubroff, Jacob G.
Publicado 2020

In vivo visualization of PARP inhibitor pharmacodynamics

por McDonald, Elizabeth S., Pantel, Austin R., Shah, Payal D., Farwell, Michael D., Clark, Amy S., Doot, Robert K., Pryma, Daniel A., Carlin, Sean D.
Publicado 2021

Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL):...

por Jimenez, Camilo, Chin, Bennett B, Noto, Richard A, Noto, Richard B, Dillon, Joseph S, Solnes, Lilja, DiPippo, Vincent A, Stambler, Nancy, Pryma, Daniel A
Publicado 2021

OR25-07 A Multi-Center, Open-Label, Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paragangliom...

por Jimenez, Camilo, Chin, Bennett B, Noto, Richard B, Dillon, Joseph Stephen, Solnes, Lilja B, DiPippo, Vincent A, Stambler, Nancy, Wong, Vivien, Pryma, Daniel A
Publicado 2020

Endocrine Surgical Procedures During COVID-19: Patient Prioritization and Time to Surgery

por Ermer, Jae P., Ballester, Jacqueline M. Soegaard, Go, Beatrice C., Philipson, Benjamin, Gabriel, Peter E., Pryma, Daniel A., Fraker, Douglas L., Kelz, Rachel R., Wachtel, Heather
Publicado 2021

PennPET Explorer: Human Imaging on a Whole-Body Imager

por Pantel, Austin R., Viswanath, Varsha, Daube-Witherspoon, Margaret E., Dubroff, Jacob G., Muehllehner, Gerd, Parma, Michael J., Pryma, Daniel A., Schubert, Erin K., Mankoff, David A., Karp, Joel S.
Publicado 2020

Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial

por Selvaraj, Senthil, Margulies, Kenneth B., Dugyala, Supritha, Schubert, Erin, Tierney, Ann, Arany, Zoltan, Pryma, Daniel A., Shah, Svati H., Rame, J. Eduardo, Kelly, Daniel P., Bravo, Paco E.
Publicado 2022

Perfusion-only imaging in pregnant women: A comparative reader study with implications for practice patterns

por Schroeder, Jennifer A., Cao, Quy, Sotirchos, Vlasios S., Gillman, Jennifer A., Anderson, Thomas, Pilati, Stamatoula, Dubroff, Jacob G., Farwell, Michael, Kozlov, Andrew, Korhonen, Katrina, Pryma, Daniel A., Pantel, Austin R.
Publicado 2022

SUN-345 Safety Analysis of High-Specific-Activity I-131 MIBG (AZEDRA(®)) in Patients with Iobenguane Scan Positive Cancers

por Jimenez, Camilo, Grewal, Ravinder, Ravizzini, Gregory, Chin, Bennett, Pampaloni, Miguel, Matthay, Katherine, Jensen, Jessica, Lin, Tess, Apfel, Stuart, White, Theresa, Stambler, Nancy, DiPippo, Vincent, Mahmood, Syed, Wong, Vivien, Pryma, Daniel
Publicado 2019

Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chem...

por Luna, José Marcio, Chao, Hann-Hsiang, Shinohara, Russel T., Ungar, Lyle H., Cengel, Keith A., Pryma, Daniel A., Chinniah, Chidambaram, Berman, Abigail T., Katz, Sharyn I., Kontos, Despina, Simone, Charles B., Diffenderfer, Eric S.
Publicado 2020

Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

por Kipnis, Sarit T., Hung, Matthew, Kumar, Shria, Heckert, Jason M., Lee, Hwan, Bennett, Bonita, Soulen, Michael C., Pryma, Daniel A., Mankoff, David A., Metz, David C., Eads, Jennifer R., Katona, Bryson W.
Publicado 2021

The Nuclear Receptor Rev-erbα Controls Circadian Thermogenic Plasticity

por Gerhart-Hines, Zachary, Feng, Dan, Emmett, Matthew J., Everett, Logan J., Loro, Emanuele, Briggs, Erika R., Bugge, Anne, Hou, Catherine, Ferrara, Christine, Seale, Patrick, Pryma, Daniel A., Khurana, Tejvir S., Lazar, Mitchell A.
Publicado 2013

Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer

por Li, Chunsheng, Wang, Junying, Hu, Jia, Feng, Yi, Hasegawa, Kosei, Peng, Xiaohui, Duan, Xingmei, Zhao, Aizhi, Mikitsh, John L., Muzykantov, Vladimir R., Chacko, Ann-Marie, Pryma, Daniel A., Dunn, Steven M., Coukos, George
Publicado 2014

A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes

por Maity, Amit, Mick, Rosemarie, Rengan, Ramesh, Mitchell, Tara C., Amaravadi, Ravi K., Schuchter, Lynn M., Pryma, Daniel A., Patsch, Dana M., Maity, Alisha P., Minn, Andy J., Vonderheide, Robert H., Lukens, John N.
Publicado 2021

Preclinical Development of [(211)At]meta- astatobenzylguanidine ([(211)At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma

por Batra, Vandana, Samanta, Minu, Makvandi, Mehran, Groff, David, Martorano, Paul, Elias, Jimmy, Ranieri, Pietro, Tsang, Matthew, Hou, Catherine, Li, Yimei, Pawel, Bruce, Martinez, Daniel, Vaidyanathan, Ganesan, Carlin, Sean, Pryma, Daniel A., Maris, John M.
Publicado 2022

Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging

por Selvaraj, Senthil, Khan, Muhammad Shoaib, Vidula, Mahesh K, Wiener, Philip C, de Feria, Alejandro E, Rojulpote, Chaitanya, Krishnan, Sheela, Tamrat, Ruth, Julien, Howard, Jacoby, Douglas, Litt, Harold, Pryma, Daniel, Dubroff, Jacob, Guerraty, Marie A, Bravo, Paco
Publicado 2021

Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

por Pryma, Daniel A., Chin, Bennett B., Noto, Richard B., Dillon, Joseph S., Perkins, Stephanie, Solnes, Lilja, Kostakoglu, Lale, Serafini, Aldo N., Pampaloni, Miguel H., Jensen, Jessica, Armor, Thomas, Lin, Tess, White, Theresa, Stambler, Nancy, Apfel, Stuart, DiPippo, Vincent A., Mahmood, Syed, Wong, Vivien, Jimenez, Camilo
Publicado 2019